Companies /Healthcare

Biogen Inc

NASDAQ: BIIB Drug Manufacturers - General
$218.50
▼ $3.00 (−1.35%) today
Markets closed · 2:13pm ET

BIIB Coverage

Page 31
8:10am ET
Health and Healthcare

Deutsche Bank Firm on Biotech Stocks to Buy

ThinkstockBiotech has strongly outperformed the S&P 500 since January of 2011. The NASDAQ Biotechnology Index (NBI) is up 90%, and the AMEX Biotechnology index (BTK) is up 50%, versus the 28% gain…

Jon C. Ogg
9:30am ET
Investing

The Big Bull Market Road Map for April

The end of March brought on the last trading of the quarter, with the S&P Index hitting new all-time closing highs in what felt like a very choppy couple of weeks. While…

Jon C. Ogg
4:16pm ET
Health and Healthcare

Another Major MS Approval Keeps Driving Biogen Idec

ThinkstockShares of Biogen Idec Inc. (NASDAQ: BIIB) did not just do well on Wednesday. The stock hit an all-time high. News hit late in the day that the U.S. Food and Drug…

Jon C. Ogg